Evidence map›Paper›PMID 29980910›Full record

ArticleInternational journal of hematology2018

Correction to: Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan.

Yasutaka Ueda, Naoshi Obara, Yuji Yonemura, Hideyoshi Noji, Masayoshi Masuko, Yoshinobu Seki, Katsuya Wada, Takahisa Matsuda, Hirozumi Akiyama, Takayuki Ikezoe and 9 more

Open access · bronzeAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 11 institutions in 1 country.

Yasutaka UedaDepartment of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Naoshi ObaraJapan PNH Study Group, Tokyo, Japan.
Yuji YonemuraJapan PNH Study Group, Tokyo, Japan.
Hideyoshi NojiJapan PNH Study Group, Tokyo, Japan.
Masayoshi MasukoDepartment of Stem Cell Transplantation, Niigata University Hospital, Niigata, Japan.
Yoshinobu SekiDepartment of Hematology, Niigata Prefectural Shibata Hospital, Shibata, Japan.
Katsuya WadaDepartment of Hematology, Matsushita Memorial Hospital, Moriguchi, Japan.
Takahisa MatsudaAlexion Pharma G.K, Tokyo, Japan.
Hirozumi AkiyamaAlexion Pharma G.K, Tokyo, Japan.
Takayuki IkezoeJapan PNH Study Group, Tokyo, Japan.
Shigeru ChibaJapan PNH Study Group, Tokyo, Japan.
Yoshinobu KandaJapan PNH Study Group, Tokyo, Japan.
Tatsuya KawaguchiJapan PNH Study Group, Tokyo, Japan.
Tsutomu ShichishimaJapan PNH Study Group, Tokyo, Japan.
Hideki NakakumaJapan PNH Study Group, Tokyo, Japan.
Shinichiro OkamotoJapan PNH Study Group, Tokyo, Japan.
Jun-Ichi NishimuraDepartment of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Yuzuru KanakuraDepartment of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Haruhiko NinomiyaJapan PNH Study Group, Tokyo, Japan. ninomiya.haruhiko.ft@u.tsukuba.ac.jp.ORCID 0000-0002-5431-7447
Fukushima Medical University · JPThe University of Osaka · JPUniversity of Tsukuba · JPFukuoka Tokushukai Hospital · JPJichi Medical University · JPKeio University · JPKumamoto University · JPKumamoto University Hospital · JPMatsushita Memorial Hospital · JPNiigata Prefectural Shibata Hospital · JPNiigata University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the original publication of this article, Tables 2, 3 and 4 were published incorrectly. The corrected tables 2, 3 and 4 are given in the following pages.

Identifiers

PMID29980910
OpenAlexW2849420952

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.